• Profile
Close

Diabetes and intracerebral hemorrhage: Baseline characteristics and mortality

European Journal of Neurology Feb 18, 2018

Liebkind R, et al. - Researchers undertook a comparative analysis of the baseline characteristics and 30-day and long-term mortality between patients with and without diabetes after an intracerebral hemorrhage (ICH), with particular emphasis on the differences between type 1 (T1D) and type 2 (T2D) diabetes. A distinct pattern of comorbidities and disease characteristics with specific differences between T1D and T2D were demonstrated by the ICH patients with diabetes. It was determined that T1D displayed a significantly higher tendency of long-term mortality after an ICH than T2D, regardless of the younger age of the patient.

Methods

  • Follow-up analysis was conducted of subjects with a first-ever ICH for a median of 2.3 years.
  • Logistic regression analysis aided in examining the factors related to case-fatality and 1-year survival among the 30-day survivors, after adjusting for demographics, comorbidities and documented ICH characteristics increasing mortality after ICH.
  • During this study, researchers compared diabetes to patients without diabetes in separate models as (1) any diabetes and (2) T1D or T2D.

Results

  • Among 969 patients, 813 (83.9%) had no diabetes, 41 (4.2%) had T1D, and 115 (11.9%) T2D.
  • Individuals with diabetes were younger, more often men, and presented more frequently hypertension, coronary heart disease, and chronic kidney disease (CKD) than patients without diabetes, exhibiting similar ICH characteristics.
  • Data revealed that T1D patients were younger, had more often CKD and brain-stem ICH, and less often atrial fibrillation and lobar ICH, than candidates with T2D.
  • It was noted that diabetes did not affect the case-fatality.
  • An independent connection was brought to light between any diabetes (OR 2.42, 1.19-4.93), T1D (5.27, 0.95-29.28), and T2D (OR 2.20, 1.04-4.67) with 1-year mortality.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay